Renal function in sheep during infusion of alkali metal ions into the renal artery.
1. The effect on renal function of 1 M solutions of LiCl, NaCl, KCl, RbCl and CsCl and 3 M-NaCl infused close-arterially to the kidney for 10 min at 0-7ml./min has been studied in nine experiments on four unilaterally nephrectomized sheep. The levels of flow, electrolyte concentration and electrolyte excretion in the urine were measured before, during and for 50 min after the infusions. 2. The infusion of 1-M-NaCl produced little change in urine flow and composition whereas 3 M-NaCl resulted in relatively small increases in urine flow and sodium excretion. 3. The infusion of lithium, potassium, rubidium and caesium resulted in marked increases in urine flow, urinary sodium concentration and excretion, urinary potassium excretion and osmolal clearance while the urinary potassium concentration decreased. 4. Changes in urine flow and urinary pH during the infusions of all the alkali ions except sodium were consistent with increased urinary bicarbonate excretion. 5. The osmolal clearance was increased by the infusion of lithium, potassium, rubidium and caesium, but equivalent increases in the rate of solutefree water reabsorption did not occur. 6. The infusion of caesium resulted in a depression of the glomerular filtration rate (G.F.R.) which was not observed when the other alkali ions were infused. 7. The effects of lithium, potassium and rubidium on urine flow and composition were rapid in onset and the residual effects on these ions, on cessation of infusion, were relatively short. The effects on caesium were slow in onset and prolonged in duration. 8. It was concluded that lithium, potassium, rubidium, and caesium altered urine flow and electrolyte excretion by acting upon common mechanisms which were predominantly intra-renal and located in the proximal segment of the nephron.
D000618:Aminohippuric Acids / Q000652:urine; D000818:Animals; D001639:Bicarbonates / Q000652:urine; D002586:Cesium / Q000494:pharmacology; D004231:Diuresis / Q000187:drug effects; D005260:Female; D005919:Glomerular Filtration Rate / Q000187:drug effects; D006400:Hematocrit; D006863:Hydrogen-Ion Concentration; D007269:Injections, Intra-Arterial; D007444:Inulin / Q000652:urine; D007668:Kidney / Q000187:drug effects*; D007671:Kidney Concentrating Ability / Q000187:drug effects; D008094:Lithium / Q000494:pharmacology; D008670:Metals / Q000494:pharmacology*; D009318:Natriuresis / Q000187:drug effects; D009994:Osmolar Concentration; D011188:Potassium / Q000097:blood / Q000652:urine; D011189:Potassium Chloride / Q000494:pharmacology; D012077:Renal Artery; D012413:Rubidium / Q000494:pharmacology; D012756:Sheep; D012964:Sodium / Q000097:blood; D012965:Sodium Chloride / Q000494:pharmacology
D000618:Aminohippuric Acids; D001639:Bicarbonates; D008670:Metals; D002586:Cesium; D012965:Sodium Chloride; D011189:Potassium Chloride; D007444:Inulin; D008094:Lithium; D012964:Sodium; D012413:Rubidium; D011188:Potassium